上海市宝山区2株人源艾伯特埃希菌的病原学特征

Etiological characteristics of two strains of human-origin Escherichia albertii in Baoshan District, Shanghai

  • 摘要:
    目的 对上海市宝山区2024年首次发现的2株艾伯特埃希菌开展病原学特征分析,探究其耐药特征、毒力特征及多位点序列分型(MLST)等,揭示其遗传进化关系,为本地艾伯特埃希菌的监测和防控提供科学依据。
    方法 本研究于2024年采集457例腹泻患者的肛拭子样本,从中分离出2株疑似艾伯特埃希菌。通过质谱分析、生化鉴定及聚合酶链反应(PCR)检测,对分离菌株进行鉴定。采用微量肉汤稀释法进行药敏试验,利用全基因组测序进行分子特征分析。
    结果 经质谱分析和PCR检测初步鉴定分离菌株为大肠埃希菌,但和大肠埃希菌的生化试验不符合。通过基因测序鉴定为艾伯特埃希菌,并分别命名为S1、S2。药敏试验显示,2株菌株均对β‑内酰胺类抗生素敏感,对多肽类抗生素中度敏感。其中,S1对氯霉素、链霉素、四环素、氟苯尼考,萘啶酸这5种药物耐药,且携带APH(6)、APH(3)、gyrAtetflor等5种耐药基因;S2则对上述药物均保持敏感。2株菌株均不含有stx毒力基因,S2存在astA毒力基因。MLST型分别为ST4638,ST4606。2株基因组大小为4.5 Mb,最近缘株为GTC14781(艾伯特埃希菌),与大肠杆菌参考基因组平均核苷酸相似度(ANI)值均低于90%。S1未检测到已收录于现有数据库中的H型抗原型别,S1与S2两者单核苷酸多态性(SNP)差异为28 267个,在与GeneBank数据库的数据比对中均未找到同源性的菌株。
    结论 宝山区首次发现2株艾伯特埃希菌。其中,S1具有较强耐药性,S2携带可引起腹泻的相关毒力基因。2株菌株遗传关系较远,呈散发状态。建议利用全基因组测序技术,加强艾伯特埃希菌的流行病学监测和实验室检测工作。

     

    Abstract:
    Objective To analyze the etiological characteristics of two strains of Escherichia albertii first identified in Baoshan District, Shanghai, in 2024, to explore their antibiotic resistance characteristics, virulence characteristics, and multilocus sequence typing (MLST) to elucidate their genetic evolutionary relationships, so as to provide a scientific basis for the surveillance and control of Escherichia albertii in the local area.
    Methods A total of 457 anal swabs were collected from patients with diarrhea in 2024, from which two suspected Escherichia albertii strains were isolated. The isolated strains were identified through mass spectrograph analysis, biochemical identification, and polymerase chain reaction (PCR) test. Microdilution broth method was used for the antimicrobial susceptibility testing, and whole-genome sequencing was performed for molecular characteristic analysis.
    Results Mass spectrograph analysis and PCR test initially identified the two strains as Escherichia coli (E. coli), but their biochemical profiles were inconsistent with those of E. coli. Genomic sequencing identified the strains as Escherichia albertii, and which were named as S1 and S2, respectively. The antimicrobial susceptibility test showed that both strains were susceptible to β‑lactam antibiotics and moderately susceptible to polypeptide antibiotics. S1 was resistant to chloramphenicol (CHL), streptomycin (STR), tetracyclin (TET), florfenicol (FFC) and nalidixic acid (NAL), and carried five resistance genes including APH(6), APH(3), gyrAtet andflor, whereas S2 was susceptible to the five antibiotics mentioned above. Neither of the two strains contained the stx virulence gene, but S2 harbored the astA virulence gene. The two Escherichia albertii strains had the MLST types of ST4638 and ST4606, respectively. The genome size of the two strains was 4.5 Mb, and the closest relative strain was GTC14781 (Escherichia albertii). The average nucleotide identity (ANI) values to the reference genome of E. coli were both below 90%. S1 did not have the H serotype defined in the current database. S1 and S2 differed by 28 267 single-nucleotide polymorphisms (SNPs), and no homologous strains were found in comparison with the data in the GeneBank database.
    Conclusion Two strains of Escherichia albertii are initially identified in Baoshan District of Shanghai. Strain S1 shows strong multidrug resistance, while strain S2 carries diarrheagenic virulence genes. The two strains have a distant genetic relationship and exhibits a pattern of sporadic occurrence. It is recommended to utilize whole-genome sequencing technology to enhance the epidemiological surveillance and laboratory detection of Escherichia albertii.

     

/

返回文章
返回